Literature DB >> 29284593

Antigen Analysis of Pre-Eclamptic Plasma Antibodies Using Escherichia Coli Proteome Chips.

Te-Yao Hsu1, Jyun-Mu Lin2,3, Mai-Huong T Nguyen2,3, Feng-Hsiang Chung2,3, Ching-Chang Tsai4, Hsin-Hsin Cheng4, Yun-Ju Lai4, Hsuan-Ning Hung4, Chien-Sheng Chen5,3,6.   

Abstract

Pre-eclampsia is one of the main causes of perinatal mortality and morbidity. Many biomarkers for diagnosing pre-eclampsia have been found but most have low accuracy. Therefore, a potential marker that can detect pre-eclampsia with high accuracy is required. Infection has been reported as a cause of pre-eclampsia. In recent years, protein microarray chips have been recognized as a strong and robust tool for profiling antibodies for infection diagnoses. The purpose of the present study was to profile antibodies in the human plasma of healthy and pre-eclamptic pregnancies to identify suitable biomarkers. In this study, an Escherichia coli chip was probed with samples from 29 individuals (16 pre-eclamptic women and 13 healthy pregnant women) to profile plasma antibodies. Bioinformatics tools were used to analyze the results, discover conserved motifs, compare against the entire human proteome, and perform protein functional analysis. An antibody classifier was identified using k-top scoring pairs and additional samples for a blinded test were collected. The findings indicated that compared with the healthy women, the pre-eclamptic women exhibited 108 and 130 differentially immunogenic proteins against human immunoglobulins G and M, respectively. In addition, pre-eclamptic women developed more immunoglobulin G but less immunoglobulin M against bacterial surface proteins compared with healthy women. The k-top scoring pairs identified five pairs of immunogenic proteins as classifiers with a high accuracy of 90% in the blind test. [AG] [ISV] GV [AE] L [LF] and [IV] [IV] RI [AG] [AD] E were the consensus motifs observed in immunogenic proteins in the immunoglobulin G and immunoglobulin M of pre-eclamptic women, respectively, whereas GA [AG] [AL] L [LF] and [SRY] [IQML] [ILV] [ILV] [ACG] GI [GH] [AEF] [AK] [ATY] [RG] N [IV] were observed in the immunoglobulins G and immunoglobulin M of healthy women, respectively.
© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Antibodies; Biomarker: Diagnostic; Plasma or serum analysis; Protein array; Systems biology; antigen; pre-eclampsia

Mesh:

Substances:

Year:  2017        PMID: 29284593      PMCID: PMC6072543          DOI: 10.1074/mcp.RA117.000139

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  59 in total

Review 1.  Could an infectious trigger explain the differential maternal response to the shared placental pathology of preeclampsia and normotensive intrauterine growth restriction?

Authors:  Peter von Dadelszen; Laura A Magee
Journal:  Acta Obstet Gynecol Scand       Date:  2002-07       Impact factor: 3.636

2.  Selective overexpression of the hypoxia-inducible transcription factor, HIF-2alpha, in placentas from women with preeclampsia.

Authors:  A Rajakumar; K A Whitelock; L A Weissfeld; A R Daftary; N Markovic; K P Conrad
Journal:  Biol Reprod       Date:  2001-02       Impact factor: 4.285

3.  Is preeclampsia an infectious disease?

Authors:  L I Trogstad; A Eskild; A L Bruu; S Jeansson; P A Jenum
Journal:  Acta Obstet Gynecol Scand       Date:  2001-11       Impact factor: 3.636

4.  Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial.

Authors:  L Poston; A L Briley; P T Seed; F J Kelly; A H Shennan
Journal:  Lancet       Date:  2006-04-08       Impact factor: 79.321

5.  Simple decision rules for classifying human cancers from gene expression profiles.

Authors:  Aik Choon Tan; Daniel Q Naiman; Lei Xu; Raimond L Winslow; Donald Geman
Journal:  Bioinformatics       Date:  2005-08-16       Impact factor: 6.937

6.  Growth in utero and serum cholesterol concentrations in adult life.

Authors:  D J Barker; C N Martyn; C Osmond; C N Hales; C H Fall
Journal:  BMJ       Date:  1993-12-11

7.  Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia.

Authors:  Sarosh Rana; S Ananth Karumanchi; Richard J Levine; Shivalingappa Venkatesha; Jose Alejandro Rauh-Hain; Hector Tamez; Ravi Thadhani
Journal:  Hypertension       Date:  2007-05-21       Impact factor: 10.190

8.  Infant growth and stroke in adult life: the Helsinki birth cohort study.

Authors:  Clive Osmond; Eero Kajantie; Tom J Forsén; Johan G Eriksson; David J P Barker
Journal:  Stroke       Date:  2007-01-11       Impact factor: 7.914

Review 9.  Pre-eclampsia: pathophysiology, diagnosis, and management.

Authors:  Jennifer Uzan; Marie Carbonnel; Olivier Piconne; Roland Asmar; Jean-Marc Ayoubi
Journal:  Vasc Health Risk Manag       Date:  2011-07-19

10.  Acute maternal infection and risk of pre-eclampsia: a population-based case-control study.

Authors:  Caroline Minassian; Sara L Thomas; David J Williams; Oona Campbell; Liam Smeeth
Journal:  PLoS One       Date:  2013-09-03       Impact factor: 3.240

View more
  1 in total

Review 1.  Developments and Applications of Functional Protein Microarrays.

Authors:  Guan-Da Syu; Jessica Dunn; Heng Zhu
Journal:  Mol Cell Proteomics       Date:  2020-04-17       Impact factor: 5.911

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.